⌘K

Login Start Free

Home/Filings/4/0001104659-21-100197

4//SEC Filing

Mann Brenda 4

Accession 0001104659-21-100197

CIK 0001372514other

View on SEC.gov Company Profile

Filed

Aug 3, 8:00 PM ET

Accepted

Aug 4, 5:45 PM ET

Size

4.7 KB

Accession

0001104659-21-100197

Insider Transaction Report

Form 4

Period: 2021-08-03

EYEGATE PHARMACEUTICALS INCEYEG

VP of Research & Development

Transactions

Tax Payment
Common Stock
2021-08-03$2.40/sh−63$151→ 15,321 total

Footnotes (1)

[F1]Sale of shares to cover taxes due on restricted stock that vested on 08/01/2021.

Documents

1 file

4
tm2124160d2_4seq1.xmlPrimary
OWNERSHIP DOCUMENT

Issuer

EYEGATE PHARMACEUTICALS INC

CIK 0001372514

Entity typeother

Related Parties

1

filerCIK 0001668858

Filing Metadata

Form type: 4
Filed: Aug 3, 8:00 PM ET
Accepted: Aug 4, 5:45 PM ET
Size: 4.7 KB

View on SEC.gov